Rethinking Clinical Trial Design to Accelerate Therapeutics for Arboviral Epidemics重新思考临床试验设计以加速治疗虫媒病毒性流行病Open Forum Infectious DiseasesIF3.82026-10-080OA
Methodological insights into intervention and outcomes in randomised controlled trials of herbal medicine for obesity: a scoping reviewtherapeutic advances in musculoskeletal diseaseIF2.82025-02-040OAAI
In vitro study on efficacy of SKF7®, a Malaysian medicinal plant product against SARS-CoV-2BMC COMPLEMENTARY MEDICINE AND THERAPIESIF3.42024-09-110OAAI
High-performance Al/Ti laminated composite via asymmetric cryorolling and its interface enhancement mechanismMATERIALS TODAY COMMUNICATIONSIF4.52024-08-011PRE
Inhibitory effect of food-functioned phytochemicals on dysregulated inflammatory pathways triggered by SARS-CoV-2: a mechanistic reviewCRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITIONIF8.82024-04-153PRE
Neurological Applications of Celery (Apium graveolens): A Scoping ReviewMOLECULESIF4.62023-08-025OAAI
Immunomodulatory Activities of Carica papaya L. Leaf Juice in a Non-Lethal, Symptomatic Dengue Mouse ModelPATHOGENSIF3.32021-04-2115OAAI
Bioavailability of Eurycomanone in Its Pure Form and in a Standardised Eurycoma longifolia Water ExtractPHARMACEUTICSIF5.52018-07-1111OAAI
Dynamic interaction of colistin and meropenem on a WT and a resistant strain of Pseudomonas aeruginosa as quantified in a PK/PD modelJOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62016-02-0445PREAI
A pharmacokinetic/pharmacodynamic model developed for the effect of colistin on Pseudomonas aeruginosa in vitro with evaluation of population pharmacokinetic variability on simulated bacterial killingJOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62014-01-2744OA
Application of a Loading Dose of Colistin Methanesulfonate in Critically Ill Patients: Population Pharmacokinetics, Protein Binding, and Prediction of Bacterial KillANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52012-08-01194OAAI
Pharmacokinetic-Pharmacodynamic Model for Gentamicin and Its Adaptive Resistance with Predictions of Dosing Schedules in Newborn InfantsANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52012-01-0180OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向